Lawson Macartney

Lawson Macartney

Vermögen: 2 Mio $ am 31.05.2026

68 Jahre
Health Technology
Consumer Services
Health Services

Profil

Dr. Lawson Macartney is a Senior Independent Non-Executive Director at Dechra Pharmaceuticals Ltd., an Independent Chairman at Viking Therapeutics, Inc. and a Member at Royal College of Veterinary Surgeons.
He is on the Board of Directors at Dechra Pharmaceuticals Ltd. and Netherlands Translational Research Center BV.
Dr. Macartney was previously employed as a Chief Executive Officer by Scout Bio, Inc., a President, Chief Executive Officer & Director by Ambrx, Inc., a Senior Vice President-Emerging Business Unit by Shire AG, a Vice President by Cardiovascular Group, a Vice President by Metabolic Research, Inc., a Senior Vice President-Global Product Strategy by GlaxoSmithKline Plc, and an Executive Director-Commercial Operations by Astra Merck, Inc. He received his undergraduate degree from the University of Glasgow School of Veterinary Medicine and a doctorate degree from the University of Glasgow.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
15.03.2026 47.965 ( 0,04 % ) 2 Mio $ 31.05.2026

Aktive Positionen von Lawson Macartney

UnternehmenPositionBeginn
VIKING THERAPEUTICS, INC. Vorsitzender 01.05.2015
DECHRA PHARMACEUTICALS Direktor/Vorstandsmitglied 01.12.2016
Corporate Officer/Principal -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Lawson Macartney

UnternehmenPositionEnde
Vorstandsvorsitzender 01.06.2017
AMBRX INC Vorstandsvorsitzender 01.06.2015
Corporate Officer/Principal 01.01.2013
GSK PLC Corporate Officer/Principal 01.01.2011
Corporate Officer/Principal 01.01.2007
Sehen Sie sich die Erfahrung von Lawson Macartney im Detail an

Ausbildung von Lawson Macartney

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

69

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen13

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Services

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Lawson Macartney